Abiopharma

🔍 Gebbia Richard (Executive)

Company: SIEBERT FINANCIAL CORP (SIEB)

Report Date: 2026-05-28

Detailed Transactions and Holdings:

• Acquired 15,000 shares of Common Stock, $0.01 par value per share at $1.86 per share (Direct)
  Date: 2026-05-28 | Code: P | equity_swap_involved: 0 | shares_owned_after: 576,273.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Common Stock, $0.01 par value per share (Direct)
  Date: 2026-05-28 | Code: H | shares_owned_after: 3,078,127.00 | Footnotes: F1
• Holds 0 shares of Common Stock, $0.01 par value per share (Direct)
  Date: 2026-05-28 | Code: H | nature_of_ownership: Control Group | shares_owned_after: 17,060,603.00 | Footnotes: F3

Footnotes:

• F1: The Reporting Person owns 3,078,127 shares of Issuer common stock.
• F2: The Reporting Person's various family members own 576,273 shares of Issuer common stock. A family member of the Reporting Person acquired 15,000 shares of Issuer common stock. These shares are included in the Reporting Person's indirect beneficial ownership holdings. The Reporting Person disclaims beneficial ownership of such shares of Issuer common stock, except to the extent of the Reporting Person's pecuniary interest therein.
• F3: The Reporting Person is part of a control group consisting of family members of the Reporting Person. Members of the control group gifted 22,500 shares of Issuer common stock to individuals not included within the control group. Additionally, a family member of a member in the control group acquired 15,000 shares of Issuer common stock. These events resulted in a net decrease of 7,500 shares of Issuer common stock to the control group. The Reporting Person disclaims beneficial ownership of such shares of Issuer common stock, except to the extent of the Reporting Person's pecuniary interest therein.